Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin

被引:10
|
作者
Isoda, Atsushi [1 ,2 ]
Miyazawa, Yuri [1 ]
Tahara, Kenichi [1 ]
Mihara, Masahiro [1 ]
Saito, Akio [1 ]
Matsumoto, Morio [1 ]
Sawamura, Morio [1 ]
机构
[1] Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, Shibukawa, Gunma, Japan
[2] Hoshi Clin, Dept Hematol, Sapporo, Hokkaido, Japan
关键词
pure red cell aplasia; pembrolizumab; programed cell death 1; immune-related adverse events; direct anti-globulin test; intravenous immunoglobulin; AUTOIMMUNE HEMOLYTIC-ANEMIA; IMMUNOTHERAPY; RITUXIMAB; LYMPHOMA;
D O I
10.2169/internalmedicine.4467-20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We herein report a 64-year-old man who was treated with pembrolizumab for relapsed Hodgkin lymphoma. After the third administration of pembrolizumab, he showed acute anemia with a positive direct antiglobulin test. Because of the markedly erythroid hypoplasia, he was diagnosed with pure red cell aplasia (PRCA) caused by pembrolizumab. He was initially treated with prednisolone, but the reticulocytes decreased after tapering prednisolone. He then received high-dose intravenous immunoglobulin (WIG) with prednisolone, and PRCA was successfully treated. Although the pathogenesis of PRCA caused by immune checkpoint inhibitors (CPIs) remains unclear, WIG treatment may be effective for some steroid-refractory CPI-induced PRCA cases.
引用
收藏
页码:2041 / 2045
页数:5
相关论文
共 50 条
  • [11] Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A
    Sato A.
    Sano F.
    Ishii T.
    Adachi K.
    Negishi R.
    Matsumoto N.
    Okuse C.
    Clinical Journal of Gastroenterology, 2014, 7 (1) : 74 - 78
  • [12] PURE WHITE CELL APLASIA TREATED BY HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
    BARBUI, T
    BASSAN, R
    VIERO, P
    MINETTI, B
    COMOTTI, B
    BUELLI, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1984, 58 (03) : 554 - 555
  • [13] Treatment with intravenous immunoglobulin in pure red cell aplasia in a patient with systemic lupus erythematosus
    Burgos, EC
    Navarro, T
    Olivé, A
    Ribera, JM
    MEDICINA CLINICA, 1999, 112 (17): : 678 - 678
  • [14] Pure red cell aplasia caused by antibody to erythropoietin successfully treated by cyclosporine administration
    Shinohara, Kenji
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (03) : 247 - 248
  • [15] A CASE OF RECCURENT THYMOMA WITH PURE RED CELL APLASIA SUCCESSFULLY TREATED BY IMMUNOSUPPRESSIVE THERAPY
    Murayama, Tomonori
    Yoshida, Yukihiro
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S431 - S431
  • [16] PURE RED-CELL APLASIA SUCCESSFULLY TREATED BY CYCLOSPORINE-A AS THE SOLE AGENT
    KWONG, YL
    LIANG, RHS
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (02) : 148 - 148
  • [17] Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib
    Goldschmidt, Neta
    Rund, Deborah
    LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 498 - 500
  • [18] REFRACTORY IDIOPATHIC PURE RED CELL APLASIA (PRCA) DARBEPOETIN DEPENDENT SUCCESSFULLY TREATED WITH ALEMTUZUMAB
    Sayas, M. J.
    Ribas, P.
    Andreu, R.
    Juan, M. L.
    Tolosa, A.
    Pedreno, M.
    Yague, N.
    Cejalvo, M. J.
    Eon, P.
    Ferrer, S.
    Rafecas, F. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 501 - 501
  • [19] Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine
    Yamazaki, Susumu
    Naito, Erika
    Sekiya, Ryu
    Yogi, Sanehiro
    Komiyama, Kenichiro
    Miyakawa, Yoshitaka
    Nagata, Makoto
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (02) : 304 - 307
  • [20] Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia
    Subtirelu, MM
    Flynn, JT
    Schechner, RS
    Pullman, JM
    Feuerstein, D
    Del Rio, M
    PEDIATRIC TRANSPLANTATION, 2005, 9 (06) : 801 - 804